SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-378514
Filing Date
2015-11-16
Accepted
2015-11-16 16:50:36
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d14311d10q.htm 10-Q 364610
2 EX-31.1 d14311dex311.htm EX-31.1 5960
3 EX-31.2 d14311dex312.htm EX-31.2 6182
4 EX-32 d14311dex32.htm EX-32 4505
  Complete submission text file 0001193125-15-378514.txt   2519659

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bgmd-20150930.xml EX-101.INS 327557
6 XBRL TAXONOMY EXTENSION SCHEMA bgmd-20150930.xsd EX-101.SCH 28462
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bgmd-20150930_cal.xml EX-101.CAL 41545
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bgmd-20150930_def.xml EX-101.DEF 197801
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bgmd-20150930_lab.xml EX-101.LAB 250978
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bgmd-20150930_pre.xml EX-101.PRE 228013
Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33827 | Film No.: 151235875
SIC: 2835 In Vitro & In Vivo Diagnostic Substances